Laboratory Corp. (LH) Extends $2.80/Share Tender for Orchid Cellmark (ORCH)
Tweet
Share
E-mail
Up)
Laboratory Corporation of America (NYSE: LH) reports it is extending until 5:00 p.m., New York City time, on October 7, 2011 LabCorp’s previously announced cash tender offer for all outstanding shares of the common stock of Orchid Cellmark Inc. (Nasdaq: ORCH).
As announced previously, on April 19, 2011, LabCorp, through its wholly owned subsidiary OCM Acquisition Corp., commenced a tender offer for all outstanding shares of Orchid at a price of $2.80 per share net to the seller in cash without interest and subject to applicable withholding taxes.
As announced previously, on April 19, 2011, LabCorp, through its wholly owned subsidiary OCM Acquisition Corp., commenced a tender offer for all outstanding shares of Orchid at a price of $2.80 per share net to the seller in cash without interest and subject to applicable withholding taxes.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mondi Says It Does Not Intend To Make An Offer For DS Smith
- Peapack-Gladstone Financial (PGC) Appoints Kate Sant'Angelo as SVP, Director of Personal Banking
- Silicon Labs (SLAB) Appoints Radhika Chennakeshavula as CIO
Create E-mail Alert Related Categories
Corporate News, Mergers and AcquisitionsRelated Entities
Laboratory Corporation/Orchid CellmarkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
